[go: up one dir, main page]

HUT63859A - Process for producing cyclopeptides and pharmaceutical compositions comprising same - Google Patents

Process for producing cyclopeptides and pharmaceutical compositions comprising same

Info

Publication number
HUT63859A
HUT63859A HU931054A HU105493A HUT63859A HU T63859 A HUT63859 A HU T63859A HU 931054 A HU931054 A HU 931054A HU 105493 A HU105493 A HU 105493A HU T63859 A HUT63859 A HU T63859A
Authority
HU
Hungary
Prior art keywords
cyclopeptides
producing
same
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
HU931054A
Other languages
English (en)
Other versions
HU9301054D0 (en
Inventor
Gerd Schnorrenberg
Rainer Palluk
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19904032269 external-priority patent/DE4032269A1/de
Priority claimed from DE19904032268 external-priority patent/DE4032268A1/de
Priority claimed from DE19904032271 external-priority patent/DE4032271A1/de
Priority claimed from DE19914117733 external-priority patent/DE4117733A1/de
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of HU9301054D0 publication Critical patent/HU9301054D0/hu
Publication of HUT63859A publication Critical patent/HUT63859A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C07K14/582—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU931054A 1990-10-11 1991-10-10 Process for producing cyclopeptides and pharmaceutical compositions comprising same HUT63859A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19904032269 DE4032269A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19904032268 DE4032268A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19904032271 DE4032271A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19914117733 DE4117733A1 (de) 1991-05-30 1991-05-30 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
HU9301054D0 HU9301054D0 (en) 1993-07-28
HUT63859A true HUT63859A (en) 1993-10-28

Family

ID=27435038

Family Applications (1)

Application Number Title Priority Date Filing Date
HU931054A HUT63859A (en) 1990-10-11 1991-10-10 Process for producing cyclopeptides and pharmaceutical compositions comprising same

Country Status (12)

Country Link
EP (1) EP0552238A1 (hu)
JP (1) JPH06501950A (hu)
KR (1) KR930702395A (hu)
AU (1) AU8736691A (hu)
CA (1) CA2089747A1 (hu)
CZ (1) CZ61893A3 (hu)
FI (1) FI931499A0 (hu)
HU (1) HUT63859A (hu)
IE (1) IE913582A1 (hu)
PL (1) PL168456B1 (hu)
SK (1) SK32693A3 (hu)
WO (1) WO1992006998A1 (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
JP2002519304A (ja) * 1998-06-24 2002-07-02 ザ ロックフェラー ユニバーシティ 細菌の干渉のための新規スタフィロコッカス（ｓｔａｐｈｙｌｏｃｏｃｃｕｓ）ペプチド
US6337385B1 (en) 1998-06-24 2002-01-08 The Rockefeller University Staphylococcus peptides for bacterial interference
FR2797689B1 (fr) * 1999-08-16 2003-06-27 Pasteur Sanofi Diagnostics Utilisation de composes synthetiques pour des immunodosages
US6455587B1 (en) * 2000-03-15 2002-09-24 Pharmacor Inc. Amino acid derivatives as HIV aspartyl protease inhibitors
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
EP1812037A4 (en) 2004-10-06 2009-11-11 Amr Technology Inc ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
EP1971615B1 (en) 2005-11-30 2014-01-01 TaiMed Biologics, Inc. Lysme-based prodrugs of aspartyl protease inhibitors and processes for their preparation
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
JP5355383B2 (ja) 2006-03-30 2013-11-27 パラティン・テクノロジーズ・インコーポレーテッド 環状ナトリウム利尿ペプチド構築物
AU2007233123A1 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US8410300B2 (en) 2006-09-21 2013-04-02 Taimed Biologics, Inc. Protease inhibitors
EP2952522B1 (en) 2007-01-31 2019-10-30 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
ES2610531T3 (es) 2007-03-28 2017-04-28 President And Fellows Of Harvard College Polipéptidos cosidos
RU2582678C2 (ru) 2010-08-13 2016-04-27 Эйлерон Терапьютикс, Инк. Пептидомиметические макроциклы
AR088392A1 (es) 2011-10-18 2014-05-28 Aileron Therapeutics Inc Macrociclos peptidomimeticos
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
MX362492B (es) 2012-02-15 2019-01-21 Aileron Therapeutics Inc Macrociclos peptidomiméticos.
AU2013337388B2 (en) 2012-11-01 2018-08-02 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
WO2015179438A1 (en) * 2014-05-20 2015-11-26 Ohio State Innovation Foundation Small molecule rac or rho inhibitors
AU2015320545C1 (en) 2014-09-24 2020-05-14 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
BR112017005598A2 (pt) 2014-09-24 2017-12-12 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
KR20170129879A (ko) 2015-03-20 2017-11-27 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도
JP2018528217A (ja) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337891C (en) * 1987-12-16 1996-01-02 John Dimaio Anf derivatives with novel bridging
US4935492A (en) * 1987-12-24 1990-06-19 California Biotechnology Inc. Cyclic analogs of atrial natriuretic peptides
DK380288D0 (da) * 1988-07-07 1988-07-07 Novo Industri As Hidtil ukendet peptider

Also Published As

Publication number Publication date
PL168456B1 (pl) 1996-02-29
CZ61893A3 (en) 1994-01-19
AU8736691A (en) 1992-05-20
FI931499L (fi) 1993-04-02
CA2089747A1 (en) 1992-04-12
SK32693A3 (en) 1993-09-09
KR930702395A (ko) 1993-09-09
IE913582A1 (en) 1992-04-22
FI931499A0 (fi) 1993-04-02
JPH06501950A (ja) 1994-03-03
WO1992006998A1 (de) 1992-04-30
HU9301054D0 (en) 1993-07-28
EP0552238A1 (de) 1993-07-28

Similar Documents

Publication Publication Date Title
HUT63859A (en) Process for producing cyclopeptides and pharmaceutical compositions comprising same
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
HUT62559A (en) Process for producing 1 alpha-hydroxy-d4-vitamins and pharmaceutical compositions comprising same
HUT63628A (en) Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same
HUT59390A (en) Process for producing quinazoline derivatives and pharmaceutical compositions comprising same
SG52322A1 (en) 3-Amidopyrazole derivatives process for preparing these and pharmaceutical compositions containing them
HUT46365A (en) Process for producing glycopeptide antibiotics and pharmaceutical compositions comprising the same
HUT59677A (en) Process for producing indol- and benzimidazol-substituted imidazol deivatives and pharmaceutical compositions containing them
HUT60784A (en) Process for producing n,o-sulfated heparosanes and pharmaceutical compositions comprising such compounds
HUT58304A (en) Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
HUT61731A (en) Process for producing glycinamide derivatives and pharmaceutical compositions comprising same
HUT49871A (en) Process for producing indolylpiperidine derivatives and pharmaceutical compositions comprising same
HUT53625A (en) Process for producing 2-iminobenzothiazole derivatives and pharmaceutical compositions comprising same
HU906358D0 (en) Process for producing nukleosides and pharmaceutical compositions containing them
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
HUT61548A (en) Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
HUT52163A (en) Process for producing antibiotic bu-3420t and pharmaceutical compositions comprising such antibiotic
HUT53620A (en) Process for producing new thiouracyl derivatives and pharmaceutical compositions comprising same
HUT54165A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising same
HUT60248A (en) Process for producing new benzo/c/phenantridinium derivatives and pharmaceutical compositions comprising same
HUT59131A (en) Process for producing imidazole derivatives and pharmaceutical compositions comprising same
HUT63629A (en) Process for producing substituted phenylquinazoline derivatives and pharmaceutical compositions comprising same
HUT49351A (en) Process for producing new condensed diazepinones and pharmaceutical compositions comprising same
HUT59154A (en) Process for producing 6-methyl-19-norsteroids and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment